Investors

Insider Transactions

Date Sorted Descending Name Title Type Shares Traded Price Range
Jan 12, 2012 ryan arthur f Director Sell 25,500 78.86 - 79.09
Jan 12, 2012 vagelos p roy Officer Disposition (Non Open Market) 3,786 n/a
Jan 11, 2012 roberts william Officer Automatic Sell 22,148 73.99 - 77.05
Jan 11, 2012 terifay robert j Officer Automatic Sell 9,019 74.20
Jan 10, 2012 goldstein joseph l Director Automatic Sell 20,000 74.35 - 75.00
Jan 10, 2012 goldstein joseph l Director Option Execute 20,000 19.69 - 23.84
Jan 10, 2012 roberts william Officer Automatic Sell 37,852 73.92 - 74.35
Jan 10, 2012 roberts william Officer Option Execute 60,000 20.32 - 21.92
Jan 10, 2012 terifay robert j Officer Automatic Sell 10,981 73.92
Jan 10, 2012 terifay robert j Officer Option Execute 20,000 21.34 - 21.92
Jan 5, 2012 yancopoulos george Officer Automatic Sell 27,713 58.00
Dec 20, 2011 goldberg murray a Officer Option Execute 2,500 11.64
Dec 16, 2011 schleifer leonard s Officer Automatic Sell 187,929 52.03
Dec 16, 2011 schleifer leonard s Officer Option Execute 250,000 28.01
Dec 14, 2011 goldberg murray a Officer Automatic Sell 4,622 51.18
Dec 14, 2011 stahl neil Officer Automatic Sell 8,411 51.18
Dec 14, 2011 yancopoulos george Officer Automatic Sell 38,516 51.18
Dec 13, 2011 gilman alfred g Director Disposition (Non Open Market) 11,875 n/a
Dec 7, 2011 roberts william Officer Disposition (Non Open Market) 5,812 n/a
Dec 7, 2011 roberts william Officer Disposition (Non Open Market) 3,647 n/a
Showing 401-420 of 773 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)